Adalimumab vs Sitagliptin

## Adalimumab vs Sitagliptin: Overview

This comparison examines the pharmacological differences between **Adalimumab** and **Sitagliptin**.

## Mechanism of Action

**Adalimumab**: Fully human anti-TNF-alpha monoclonal antibody.

**Sitagliptin**: DPP-4 inhibitor increasing incretin levels.

## Pharmacokinetics

**Half-life**: Adalimumab — 14 days; Sitagliptin — 12.4 hours.

## Chemical Properties

**Molecular Formula**: Adalimumab — N/A; Sitagliptin — C16H15F6N5O.

**Molecular Weight**: Adalimumab — N/A; Sitagliptin — 407.3140 g/mol.

**Type**: Adalimumab — Antibody; Sitagliptin — Small molecule.